CIK: 0001595851 · Show all filings
Period: Q1 2021 (← Previous) (Next →)
Filing Date: Aug 11, 2021
Total Value: $425M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Share Price | Est. Cost/Share | Unrealized @ Report Date | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|---|
| QQQ | INVESCO QQQ TR | 150,000 | $47.87M | 11.3% | $319.13 | — | — | Put | 46090E103 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 1,175,000 | $26.27M | 6.2% | $22.36 | $18.21 | +24.1% | COM | 87164F105 |
| — | TRILLIUM THERAPEUTICS INC | 1,950,000 | $20.94M | 4.9% | $10.74 | $7.71 | — | COM NEW | 89620X506 |
| ARKG | ARK ETF TR | 200,000 | $17.75M | 4.2% | $88.73 | — | — | Put | 00214Q302 |
| ASND | ASCENDIS PHARMA A/S | 135,000 | $17.4M | 4.1% | $128.88 | $130.02 | — | SPONSORED ADR | 04351P101 |
| KURA | KURA ONCOLOGY INC | 600,000 | $16.96M | 4.0% | $28.27 * | $28.64 | +10.5% | COM | 50127T109 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | 500,000 | $15.83M | 3.7% | $31.66 * | $24.73 | +67.6% | COM | 462260100 |
| FATE | FATE THERAPEUTICS INC | 185,000 | $15.25M | 3.6% | $82.45 * | $32.72 | +192.8% | COM | 31189P102 |
| XENE | XENON PHARMACEUTICALS INC | 850,000 | $15.21M | 3.6% | $17.90 * | $13.60 | +24.6% | COM | 98420N105 |
| ACRS | ACLARIS THERAPEUTICS INC | 600,000 | $15.12M | 3.6% | $25.20 * | $4.22 | +363.6% | COM | 00461U105 |
| RCKT | ROCKET PHARMACEUTICALS INC | 325,000 | $14.42M | 3.4% | $44.37 * | $19.92 | +175.6% | COM | 77313F106 |
| COGT | COGENT BIOSCIENCES INC | 1,600,000 | $14.05M | 3.3% | $8.78 * | $10.56 | -8.9% | COM | 19240Q201 |
| ARVN | ARVINAS INC | 205,000 | $13.55M | 3.2% | $66.10 * | $28.07 | +172.5% | COM | 04335A105 |
| APLS | APELLIS PHARMACEUTICALS INC | 225,000 | $9.655M | 2.3% | $42.91 * | $42.30 | +11.9% | COM | 03753U106 |
| TGTX | TG THERAPEUTICS INC | 200,000 | $9.64M | 2.3% | $48.20 | $18.29 | +162.7% | COM | 88322Q108 |
| — | VISTAGEN THERAPEUTICS INC | 4,143,702 | $8.826M | 2.1% | $2.13 | $2.02 | — | COM NEW | 92840H202 |
| — | MIRATI THERAPEUTICS INC | 50,000 | $8.565M | 2.0% | $171.30 | $82.63 | — | COM | 60468T105 |
| — | VERONA PHARMA PLC | 939,043 | $7.85M | 1.8% | $8.36 | $6.53 | — | SPONSORED ADS | 925050106 |
| ALDX | ALDEYRA THERAPEUTICS INC | 650,000 | $7.722M | 1.8% | $11.88 * | $4.21 | +173.2% | COM | 01438T106 |
| — | MERSANA THERAPEUTICS INC | 450,000 | $7.281M | 1.7% | $16.18 | $10.98 | — | COM | 59045L106 |
| — | IVERIC BIO INC | 1,125,000 | $6.953M | 1.6% | $6.18 | $7.44 | — | COM | 46583P102 |
| IWM | ISHARES TR | 30,000 | $6.628M | 1.6% | $220.93 | $220.93 | — | RUSSELL 2000 ETF | 464287655 |
| — | CONSTELLATION PHARMCETICLS I | 275,000 | $6.432M | 1.5% | $23.39 | $42.72 | — | COM | 210373106 |
| BIIB | BIOGEN INC | 20,000 | $5.595M | 1.3% | $279.75 * | $270.70 | -0.4% | COM | 09062X103 |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 250,000 | $5.15M | 1.2% | $20.60 * | $22.96 | 0.0% | COM NEW | 15117B202 |
| — | SATSUMA PHARMACEUTICALS INC | 904,225 | $5.136M | 1.2% | $5.68 | $10.24 | — | COM | 80405P107 |
| MLTX | HELIX ACQUISITION CORP | 500,000 | $5.118M | 1.2% | $10.24 | $11.37 | — | COM CL A | G4444C102 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 500,000 | $5.085M | 1.2% | $10.17 | $4.33 | +137.9% | COM | 09058V103 |
| — | ESSA PHARMA INC | 175,000 | $5.084M | 1.2% | $29.05 | $29.05 | — | COM NEW | 29668H708 |
| — | CATALYST BIOSCIENCES INC | 1,000,000 | $5.04M | 1.2% | $5.04 | $5.04 | — | COM NEW | 14888D208 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 300,000 | $5.013M | 1.2% | $16.71 * | $18.72 | 0.0% | COM | 92790C104 |
| NUVB | NUVATION BIO INC | 500,000 | $4.964M | 1.2% | $9.93 * | $11.18 | 0.0% | COM CL A | 67080N101 |
| — | CURIS INC | 425,000 | $4.811M | 1.1% | $11.32 | $8.19 | — | COM NEW | 231269200 |
| BCYC | BICYCLE THERAPEUTICS PLC | 150,000 | $4.481M | 1.1% | $29.87 | $29.87 | — | SPONSORED ADS | 088786108 |
| — | FIBROGEN INC | 125,000 | $4.339M | 1.0% | $34.71 | $34.71 | — | COM | 31572Q808 |
| IMUX | IMMUNIC INC | 265,000 | $4.224M | 1.0% | $15.94 * | $16.38 | +3.6% | COM | 4525EP101 |
| IMVT | IMMUNOVANT INC | 250,000 | $4.01M | 0.9% | $16.04 * | $11.17 | +136.1% | COM | 45258J102 |
| — | SIERRA ONCOLOGY INC | 200,000 | $3.446M | 0.8% | $17.23 | $16.03 | — | COM NEW | 82640U404 |
| NVAX | NOVAVAX INC | 17,500 | $3.173M | 0.7% | $181.31 * | $199.27 | 0.0% | COM NEW | 670002401 |
| FOLD | AMICUS THERAPEUTICS INC | 265,000 | $2.618M | 0.6% | $9.88 * | $14.57 | +6.2% | COM | 03152W109 |
| — | KADMON HLDGS INC | 600,000 | $2.334M | 0.5% | $3.89 | $3.89 | — | COM | 48283N106 |
| — | SAGE THERAPEUTICS INC | 30,000 | $2.246M | 0.5% | $74.87 | $74.87 | — | COM | 78667J108 |
| — | CTI BIOPHARMA CORP | 750,000 | $2.183M | 0.5% | $2.91 | $3.22 | — | COM | 12648L601 |
| — | PRECISION BIOSCIENCES INC | 200,000 | $2.07M | 0.5% | $10.35 | $10.35 | — | COM | 74019P108 |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 100,000 | $2.06M | 0.5% | $20.60 * | $22.96 | 0.0% | Put | 15117B202 |
| — | CHIMERIX INC | 200,000 | $1.928M | 0.5% | $9.64 | $9.64 | — | COM | 16934W106 |
| — | CASI PHARMACEUTICALS INC | 650,000 | $1.56M | 0.4% | $2.40 | $2.40 | — | COM | 14757U109 |
| — | APTEVO THERAPEUTICS INC | 50,000 | $1.526M | 0.4% | $30.52 | $36.66 | — | COM NEW | 03835L207 |
| — | OTONOMY INC | 450,000 | $1.148M | 0.3% | $2.55 | $4.29 | — | COM | 68906L105 |
| — | FREQUENCY THERAPEUTICS INC | 100,000 | $950K | 0.2% | $9.50 | — | — | Put | 35803L108 |